Author

Michael Goodman

University of UtahPrimary ORCID profile (0000-0002-3372-3585 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Michael GoodmaniD2 papers · Vanderbilt University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrew Paul LandstromiD· 1 shared Ava Leonelli· 1 shared Benjamin WerbneriD· 1 shared Crystal F. Davey· 1 shared Marta W. SzulikiD· 1 shared Martin G. GolkowskiiD· 1 shared Mira Hua· 1 shared Omid Mohammad Tavakoli‐RouzbehaniiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Andrew Paul LandstromORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Perm1 Gene Therapy Mitigates PRDM16-Associated Cardiomyopathy

Omid Mohammad Tavakoli‐Rouzbehani, Sophie L. Stephens, Benjamin Werbner, Marta W. Szulik, Sun Bo, Mira Hua, Shinya Watanabe, Ava Leonelli, Michael Goodman, Ryan D. Bia, Crystal F. Davey, Martin G. Golkowski, Sarah Franklin, Andrew Paul Landstrom, Sihem Boudina

This study identifies PERM1 as a downstream target of PRDM16 and shows that Perm1 gene therapy improves cardiomyopathy in Prdm16 knockout mice through mitochondrial and sarcomere preservation.

bioRxiv · Apr 15, 2026 · PreprintPhysiology